Last Funding Type: Series B
Total Funding: 371217878.0
Last Funding Date: 2020-05-27
Funding Status: IPO
Employee Number: 101-250
Estimated Revenue: $10M to $50M
Investors Number: 12.0
Founded Date: 2012-01-01
Headquarters: Vancouver, British Columbia, Canada
Industry: Early Drug Development